What is King Pharmaceuticals's international — year 9?

King Pharmaceuticals (KG) reported international — year 9 of -0.7% in Q4 2025.

What does international — year 9 mean?

Reflects the financial performance and operational results of the International insurance product line during the ninth year of the reporting cycle. This metric is used to evaluate the effectiveness of long-term strategic initiatives and risk management practices in international markets. It provides a view of the segment's resilience and maturity as it approaches a decade of operations.

King Pharmaceuticals KG International — Year 9

Other product segments

European Hospital Liability

4.9%—

General Liability

3.8%—

Commercial Auto Liability

1.6%—

All other lines

-0.4%—

Similar metrics at other companies

CNAInternational — Year 9

2.8%—

CNAInternational — Year 10

1.3%—

CNAInternational — Year 8

2.6%—

CNAInternational — Year 7

5.6%—

AXSInsurance — Year 9

6.5%—

GLREHealth — Year 9

0%—

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's international — year 9.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's international — year 9?: King Pharmaceuticals (KG) reported international — year 9 of -0.7% in Q4 2025.
What does international — year 9 mean?: Reflects the financial performance and operational results of the International insurance product line during the ninth year of the reporting cycle. This metric is used to evaluate the effectiveness of long-term strategic initiatives and risk management practices in international markets. It provides a view of the segment's resilience and maturity as it approaches a decade of operations.